Pharmaceutical Biotechnology and Drug Design
The Pharmaceutical Sciences and Drug Design program is geared toward designing effective new drug therapies while minimizing adverse effects. Students can receive didactic and laboratory training in the design and development of pharmacological compounds together with the disciplines of molecular and cellular pharmacology and pharmacodynamics, medicinal chemistry, pharmacokinetics, pharmaceutics and toxicology. Research in the program involves a diverse range of therapeutic areas involves cancer, cardiovascular, dermatological, immune-mediated, and neurological diseases.
Related Conference of Pharmaceutical Biotechnology and Drug Design
Pharmaceutical Biotechnology and Drug Design Conference Speakers
Recommended Sessions
- Applications of Food Biotechnology
- Biochemistry
- Bioprocess and Fermentation Technology
- Biotechnology
- Biotechnology in Dentistry
- Cancer Biotechnology
- Cell Biology
- Gene and Cellular Therapies
- Genetic Engineering
- Genetics and Molecular Biotechnology
- Immunology
- Industrial and Environmental Biotechnology
- Pharmaceutical Biotechnology and Drug Design
- Protein Engineering
- Tissue Engineering
Related Journals
Are you interested in
- Advances in Separation Techniques - ANALYTICA ACTA 2024 (France)
- Analytical Chemistry and Methodology - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Clinical Chemistry - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Thermal analysis - ANALYTICA ACTA 2024 (France)
- Bioanalytical Methodology - ANALYTICA ACTA 2024 (France)
- Biochemistry - ANALYTICA ACTA 2024 (France)
- Biomarkers & Next-Generation Sequencing - Biomarkers 2024 (Italy)
- Biomarkers based on epidemiological investigations - Biomarkers 2024 (Italy)
- Biomarkers for Cancer Diagnosis - Biomarkers 2024 (Italy)
- Biomarkers for Early Diagnosis and Prognosis - Biomarkers 2024 (Italy)
- Biomarkers for non-cancerous diseases - Biomarkers 2024 (Italy)
- Biomarkers in Diagnosis: Challenges and Approaches - Biomarkers 2024 (Italy)
- Biomarkers in Disease Treatment - Biomarkers 2024 (Italy)
- Biomarkers in Drug discovery and development - Biomarkers 2024 (Italy)
- Biomarkers in Immune-Oncology - Biomarkers 2024 (Italy)
- Biomarkers of Cardiovascular disorders - Biomarkers 2024 (Italy)
- Biomarkers of Disorders of the Nervous System - Biomarkers 2024 (Italy)
- Biomarkers: Validation & Verification - Biomarkers 2024 (Italy)
- Biopolymers and Biomaterials - ANALYTICA ACTA 2024 (France)
- Chromatography - ANALYTICA ACTA 2024 (France)
- Clinical and Biomedical Engineering - Biomarkers 2024 (Italy)
- Clinical Diagnostics Equipment and Kits - ANALYTICA ACTA 2024 (France)
- Clinical Research & Biomarkers - Biomarkers 2024 (Italy)
- Discovery of new biomarkers/validation/technologies - Biomarkers 2024 (Italy)
- Electrophoresis - ANALYTICA ACTA 2024 (France)
- Entrepreneur Investments Meet - Biomarkers 2024 (Italy)
- Environmental Analytical Chemistry - ANALYTICA ACTA 2024 (France)
- Genomic Biomarkers in Clinical Development - Biomarkers 2024 (Italy)
- Hyphenated Techniques - ANALYTICA ACTA 2024 (France)
- Imaging Technologies and Diagnostic tests of Biomarkers - Biomarkers 2024 (Italy)
- Innovation in Food Analysis & Testing - ANALYTICA ACTA 2024 (France)
- Mass Spectrometry - ANALYTICA ACTA 2024 (France)
- Method development and validation - ANALYTICA ACTA 2024 (France)
- Microscopy - ANALYTICA ACTA 2024 (France)
- New Instrumentation and Equipment - ANALYTICA ACTA 2024 (France)
- Novel Optical Sensors and Biosensors - ANALYTICA ACTA 2024 (France)
- Pharmaceutical Analytics - ANALYTICA ACTA 2024 (France)
- Polymer Science and Material Science - ANALYTICA ACTA 2024 (France)
- Proteomics and its applications - ANALYTICA ACTA 2024 (France)
- Regulatory issues and Biosafety challenges in bioanalysis - ANALYTICA ACTA 2024 (France)
- Regulatory Issues and Biosafety Challenges in Bioanalysis - ANALYTICA ACTA 2024 (France)
- Spectroscopy - ANALYTICA ACTA 2024 (France)